-
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-{[(4-nitrophenyl)methyl]sulfanyl}-9H-purin-9-yl)oxolane-3,4-diol
-
ChemBase ID:
131226
-
Molecular Formular:
C17H17N5O6S
-
Molecular Mass:
419.41178
-
Monoisotopic Mass:
419.08995429
-
SMILES and InChIs
SMILES:
c1cc(ccc1CSc1c2c(ncn1)n(cn2)[C@H]1[C@@H]([C@@H]([C@H](O1)CO)O)O)[N+](=O)[O-]
Canonical SMILES:
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2SCc1ccc(cc1)[N+](=O)[O-]
InChI:
InChI=1S/C17H17N5O6S/c23-5-11-13(24)14(25)17(28-11)21-8-20-12-15(21)18-7-19-16(12)29-6-9-1-3-10(4-2-9)22(26)27/h1-4,7-8,11,13-14,17,23-25H,5-6H2/t11-,13-,14-,17-/m1/s1
InChIKey:
DYCJFJRCWPVDHY-LSCFUAHRSA-N
-
Cite this record
CBID:131226 http://www.chembase.cn/molecule-131226.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-{[(4-nitrophenyl)methyl]sulfanyl}-9H-purin-9-yl)oxolane-3,4-diol
|
|
|
IUPAC Traditional name
|
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-{[(4-nitrophenyl)methyl]sulfanyl}purin-9-yl)oxolane-3,4-diol
|
|
|
Synonyms
|
NBMPR
|
NBTI
|
S-(4-Nitrobenzyl)-6-thioinosine
|
6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine
|
6-[(4-硝基苄基)硫代]-9-β-D-呋喃核糖基嘌呤
|
S-(4-硝基苄基)-6-硫肌苷
|
|
|
CAS Number
|
|
EC Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.454004
|
H Acceptors
|
9
|
H Donor
|
3
|
LogD (pH = 5.5)
|
0.8909769
|
LogD (pH = 7.4)
|
0.9263837
|
Log P
|
0.92685854
|
Molar Refractivity
|
103.2406 cm3
|
Polarizability
|
39.756 Å3
|
Polar Surface Area
|
159.34 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
N2255
|
Biochem/physiol Actions Potent adenosine uptake inhibitor Inhibitor of equilibrative nucleoside transporters (ENTs), particularly adenosine transporters, in central nervous system1 and vascular smooth muscle.2 |
Sigma Aldrich -
N127
|
Biochem/physiol Actions Inhibitor of equilibrative nucleoside transporters (ENTs), particularly adenosine transporters, in central nervous system1 and vascular smooth muscle.2 |
Sigma Aldrich -
861499
|
Application A very potent inhibitor of nucleoside transport. NBMPR, in cultures, binds tightly but reversibly to tumor membrane sites associated with the nucleoside transport mechanism and is, therefore, a useful tool for cancer research. Biochem/physiol Actions Inhibitor of equilibrative nucleoside transporters (ENTs), particularly adenosine transporters, in central nervous system1 and vascular smooth muscle.2 |
PATENTS
PATENTS
PubChem Patent
Google Patent